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e.2012.08Abstract Using dilatation and curettage (D&C) without prior cervical ripening in the termination
of the first trimester missed miscarriage may often cause a concern because of the associated com-
plications. Our aim of this study was to compare the frequency of complications of dilatation and
curettage with medical method. A prospective comparison study was carried out in Al-Thawra Gen-
eral Hospital Sana’a over a year (from Dec. 1st 2010 to Nov. 31st 2011). Eligible women were ran-
domized into surgical group (n= 55) and medical group (n= 52). Misoprostol 400 lg was given
for the medical group intravaginally as initial dose followed by 200 lg every 4 h vaginally. Dilata-
tion and curettage was performed for the surgical group. All participants were invited to attend a
follow-up visit one week later. The complications were recorded during the procedure, before dis-
charge and at follow-up. The success rate of medical group was 80.7% (95%, CI: 69.97–91.43) and
100% for the surgical group. Infection had occurred in 3.8% of the medical vs. 1.8% of the surgical
group (p= 0.967), hemorrhage was recorded in 7.7% vs. 5.4% of the medical and surgical group
respectively (p= 0.928). Only one patient of the medical group required readmission for blood
transfusion. The mean induction abortion time was 20.4 ± 8.3 h. No other major complication
was observed in both groups. We concluded that dilatation and curettage is safe and acceptable
in terms of more rapid evacuation and lower complication rates compared to medical method.
ª 2012 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. All rights
reserved.1. Introduction
Traditionally, the first trimester miscarriage, is terminated by
surgical evacuation of the uterus.1,2 Surgical method datesA.H. Alharazi).
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were described.3 Although, this procedure was introduced to
reduce the risk of infection and hemorrhage, it is reported to
be associated with many complications including cervical trau-
ma, perforation of the uterus and endometritis.4 In addition,
uterine synechia, reduced fertility, tubal damage and pelvic
pain have been reported as long term complications.4 In recent
times as a result of positive experiences with prostaglandin
analog (most commonly misoprostol), the medical termination
of the first trimester miscarriage is accepted as a safe and effec-
tive alternative.5 However, this method is not without its inher-
ent complications like the need for emergency surgicaland hosting by Elsevier B.V. All rights reserved.
14 A.A. Shuaib, A.H. Alharazievacuation, pain, an increase in induction abortion time, and
also an increase in the analgesic requirement.3,5
1.1. Aim of the study
The aim of this study was to compare the complications of sur-
gical evacuation of the uterus with medical method in the man-
agement of the first trimester missed miscarriage.
2. Methods
This study was carried out in Al-Thawra General Hospital,
Sana’a throughout a year (from Dec. 1st 2010 to Nov. 31st
2011). The diagnosis of missed miscarriage and gestational
age were confirmed by trans-abdominal/vaginal ultrasonogra-
phy whichever was feasible within the department. The exclu-
sion criteria were previous uterine scar, evidence of cardiac,
hepatic or renal disease, and contraindications for misoprostol
use. Also any woman with bleeding in the past 24 h or severe
lower abdominal pain was excluded. One hundred and seven
women had met our criteria and given the consent to partici-
pate in the study. They received pre-procedure counseling with
information about the success rate and side-effects of both
surgical and medical methods and their preferences were
noted. Fifty-five women (n = 55) were selected randomly to
undergo surgical evacuation as dilatation and curettage
(D&C) and 52 women to receive medical termination. The
two groups were comparable with respect to maternal age,
parity, and weeks of gestational age. Demographic data and
reproductive histories were obtained.
2.1. Patients
For the first group the surgical evacuation was arranged within
3–6 h fasting after the diagnosis under general anesthesia. Wo-
men allocated to medical termination received misoprostol
(cytotec, Searle) two tablets (400 lg) vaginally into the poster-
ior fornix as an initial dose followed by one tablet (200 lg)
intravaginally every 4 h until the effect was achieved or a max-
imum of 48 h had elapsed. Vital signs and cervical status were
assessed as standard. Also women were assessed for the medi-
cation’s adverse effects. Analgesia was given as needed in the
form of Tramadol intramuscular injection. Induction to abor-
tion interval was defined as the time in hours from initiation of
drug until the expulsion of the products of conception (POC),
and the medical success was defined as complete expulsion of
the POC without the need for surgical or manual evacuation
and confirmed by ultrasonography. After abortion, all womenTable 1 Characteristics of the women.
Surgical (n= 55) Medical (n= 52) p value
Age (years) 27.7 ± 5.7 28.9 ± 5.6 NS
Primigravida 12 (21.8) 15 (28.8) NS
Multigravida 43 (78.1) 37 (71.7) NS
Gestational age (weeks)
7–8 11 (20) 13 (25)
9–10 21 (38.1) 18 (34.6)
11–12 23 (41.8) 21 (40.3)
Previous abortion 17 (30.9) 19 (36.5) NSin both groups were given antibiotics. The antibiotics used
routinely are ampicillin, gentamycin and metronidazole for
3–5 days because of the high incidence of infection associated
with missed miscarriage in our setting. All cases were observed
in the ward for at least 6 h and then discharged with a 1-week
follow-up visit schedule. Rh–anti-D immunoglobulin was gi-
ven for Rh-negative women. During the follow-up visit, they
were assessed for infection, bleeding or any other complica-
tions. Also they were asked about their satisfaction of the pro-
cedure they had undertaken and the choice of management in
a future miscarriage. The study protocol was approved by the
hospital ethics committee.
2.2. Statistical analysis
The data were analyzed using SPSS (version 13, Chicago, IL,
USA). The continuous variables are presented as mean ± SD,
and proportion as appropriate. Comparisons were carried out
with the use of independent t-test. The v2 or the Fisher’s exact
test was used for independent nominal data. Ninety-five per-
cent confidence interval (CI) was calculated. A p value of
<0.05 was considered significant.
3. Results
Over the study period, 107 women were diagnosed as having
missed miscarriage and included in this study. The demo-
graphic data of both groups were summarized in Table 1.
There were no significant differences between the two groups
as regards the age, gravidity, gestational age or previous his-
tory of miscarriage (p = 0.683). Of the 52 women who were
allocated to receive intravaginal misoprostol, more than three
quarters (n = 42%, 80.7%, 95% CI = 69.97–91.43) achieved
a successful complete expulsion of the products of conception.
Of these, 11 women (21.15%) were nulliparas and 31women
(59.6%) were multiparas. The difference between them was
statistically insignificant (p = 0.249). Ten cases (10/52) re-
quired surgical evacuation. The indication for surgical inter-
vention was incomplete abortion. The mean induction to
abortion interval was 20.4 ± 8.3 h. After 12 h of induction
the complete abortion was achieved in 21.1% of women and
after 24 h in 57.7% of cases. Parenteral analgesia was used
in 71.1% of women during the course of medical management.
There were no significant differences between the two groups
as regards infection and bleeding (p > 0.05). Misoprostol side
effects in terms of vomiting, pyrexia and diarrhea were ob-
served in 13.4%. In surgical group, post abortion vomiting
was detected in 20% of cases and anesthesia related transient
hallucination was present in 12.7%. The clinical findings are
summarized in Table 2.
4. Discussion
Our study shows that the medical management of the first tri-
mester missed miscarriage using intravaginally misoprostol
was a highly effective modality. The success rate of 80.7% re-
ported in our study is in line with the previous study.1 The suc-
cess rates of medical evacuation vary from 25% up to 97% for
oral, sublingual or vaginal misoprostol in different studies.6
These variations between studies probably reflect the different
misoprostol regimens used, routes of administration, and the
Table 2 Clinical findings.
Surgical (n = 55) Medical (n = 52) 95% CI p value
Misoprostol doses _ 5.11 ± 2
Induction-abortion time (h) _ 20.4 ± 8.3
Need for evacuation _ 10 (19.3)
Analgesia need _ 37 (71.15)
Infection 1 (1.8) 2 (3.8) (1.14–10.14) NS
Bleeding, total 3 (5.4) 4 (7.7) (8.96–13.56) NS
Spotting 3 (5.4) 3 (5.8)
Severe _ 1 (1.9)
Blood transfusion _ 1 (1.9)
Cervical trauma _ _
Misoprostol side-effects _ 7 (13.4)
Anesthesia side-effects 18 (32.7) _
Readmission after discharge _ 1 (1.9)
Women’s preference 29 (52.7) 41 (78.8) (6.98–42.2) 0.08
Women’s satisfaction 51 (92.7) 38 (73) (3.94–35.4) 0.01
CI = Confidence interval; NS = Non-significant.
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alone because it is reported that the addition of mifepristone
offers no advantage compared with misoprostol as initial treat-
ment.7 Also it is reported that repeated intravaginal doses have
higher success rates than single oral route.1 In addition, the
vaginal administration of misoprostol appears to have lower
rates of medication side effects.8
The present study revealed that in surgical evacuation
group only one woman (1.8%) had post abortion infection
and no cases had cervical laceration, perforation or required
blood transfusion. In contrast, one patient (1.9%) of the med-
ical group had severe bleeding and required blood transfusion.
These favorable outcomes document the safety of the surgical
method, which in part is related to the presence of experienced
physicians as previous studies reported.9 However, surgical
evacuation offers many advantages compared to medical man-
agement. It is a quick procedure being accomplished in less
than 30 min and performed under controlled timing. The pa-
tients commonly return home within a few hours post evacua-
tion and to the work within the next few days.10 Also, the
controlled timing of the surgical procedure can be of benefit
to women with specific medical disorders.10 It is reported that
the overall incidence of major complications in surgical evacu-
ation reported is less than 3%.11
We found that the infection rate associated with medical
group was higher than that of surgical group. This finding dis-
agreed with the other study that showed medical termination
may have a lower infection risk as compared to surgical evac-
uation.12 It is possible that the small sample size of our study
and the chance of selection bias might present. Pain during the
course of medical evacuation was observed in 71.1% of our
series and adequately controlled by analgesia. Misoprostol re-
lated side effects such as nausea, vomiting, and diarrhea are
well known and presented in 13.4% of our cases. However,
abundant data support the practice of medical management
for early pregnancy failure to avoid the risk of infection, trau-
ma, and anesthesia related to surgical evacuation.5 The disad-
vantage of this method is the prolonged induction abortion
intervals which indicate an average of two additional days of
vaginal bleeding and pain. The other disadvantage is the need
for unplanned surgical intervention for unresponsive women.In the literature there is growing evidence as regards the safety
and efficacy of at home self-administration of misoprostol.13,14
However, using of misoprostol in rural settings of the poor
countries including Yemen where the facilities are unavailable
for immediate surgical intervention once excessive bleeding oc-
curred could be a concern. Furthermore, in these settings the
diagnosis of ectopic or molar pregnancy might be missed
and therefore increased the complication rates.
Our study demonstrated that 78.8% of patients recom-
mended medical termination vs. 52.7% for surgical evacuation.
Several studies have found that most women will choose the
medical option when it exists because it is non-invasive, safe
and assures more privacy and autonomy.15,16 We found that
the patient’s satisfaction following medical abortion was lower
than the success rate reported (38/42). The possible reasons
were prolonged period before complete expulsion of the abor-
tion and experienced pain during the course of management.
The strong point in our study is that we compared the med-
ical method of termination with unprimed cervix using sharp
curette (D&C) rather than suction curettage which poses even
less complications. However, the information derived from this
study will be useful for physicians who may choose the medical
option solely to avoid the complications of surgical method
and also for the abortion providers to exercise training of
the procedure so as to offer the patients such option safely.
The weakness of this study should be emphasized. First, the
long-term complications such as uterine synechia and fertility
related problems were not assessed because a prospective
long-term follow-up was impossible for patients who had come
from different areas in the country and further research in this
area is needed. Second, similarly we could not study the cost
issue because our hospital is not a private and offers most ser-
vices with a low-fee.5. Conclusion
With appropriate procedure training, surgical evacuation of
the uterus for the first trimester missed abortion is being asso-
ciated with low rate of complications, shorter evacuation time,
and therefore a shorter length of hospital stay. The procedure
16 A.A. Shuaib, A.H. Alharaziseems more suitable for a woman who does not wish to under-
go labor discomfort too early.
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